Foretinib (GSK1363089)|N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹..
| Foretinib (GSK1363089)|N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺 基本信息 更多信息 |
中文名称: | N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺 | 中文同义词: | (试剂)FORETINIB (GSK1363089, XL880);N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺;HGFR和VEGFR抑制剂(FORETINIB);化合物FORETINIB;N-(3-氟-4-((-甲氧基-7-(3-吗啉代丙氧基)喹啉-4-基)氧基)苯基)-N-(4-氟苯基)环丙烷-1,1-二甲酰胺;N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺;FORETINIB (GSK1363089),抑制剂 | 英文名称: | Foretinib (GSK1363089) | 英文同义词: | GSK 1363089;N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;XL-880,Foretinib;XL880(GSK1363089);FORETINIB GLAXOSMITHKLINE PAPILLARY RENAL CELL CARCINOMA PHASE IIRSCH. TRIANGLE PARK, NC (SEE ALSO HEAD/NECK) (888) 825-5249;foretinib
N1-{3-fluoro-4-[(6-(Methyloxy)-7-{[3-(4-Morpholinyl)propyl]oxy}-4-quinolinyl)oxy]phenyl}-N1'-(4-fluorophenyl)-1,1-cyclopropanedicarboxaMide;Foretinib (GSK1363089, XL880) | CAS号: | 849217-64-7 | 分子式: | C34H34F2N4O6 | 分子量: | 632.65 | EINECS号: | | |
|
按国家浏览Foretinib (GSK1363089)国外供应商 |
中国供应商 |
Foretinib (GSK1363089) 推荐供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
|